Live from ASH 2024 | Ascentage Pharma Releases Updated Data of Bcl-2 Inhibitor Lisaftoclax in MDS that Demonstrates Potential Clinical Benefits and Favorable Safetyby December 10, 2024PR Newswire
Live from ASH 2024 | Oral Report Features Encouraging Data of Ascentage Pharma’s Bcl-2 Inhibitor Lisaftoclax in R/R MM, Including a Median PFS Over 9 Monthsby December 10, 2024PR Newswire
District neighboring Hong Kong attracts global investment for commerce, trade, and cultural tourismby December 10, 2024PR Newswire
Live from ASH 2024 | First Dataset of Olverembatinib in Combination with Bcl-2 Inhibitor Lisaftoclax Demonstrates Potential Clinical Benefits as a Chemotherapy-Free Regimen for Children with R/R Ph+ ALLby December 10, 2024PR Newswire
Stellantis and CATL to Invest Up to €4.1 Billion in Joint Venture for Large-Scale LFP Battery Plant in Spainby December 10, 2024PR Newswire
State Grid Xuzhou Power Supply Company: Helping to boost the “green content” of industrial developmentby December 10, 2024PR Newswire
BingX Sponsors Taipei Blockchain Week for the Third Year, Driving Web3 Innovationby December 10, 2024PR Newswire
Bring Christmas Cheer to Your Home with Yaber Projectors: Holiday Sale Now Live on Amazonby December 10, 2024PR Newswire
Waters Highlights Continued Progress Towards Sustainability Commitmentsby December 10, 2024PR Newswire
Terumo Health Outcomes and Medis Medical Imaging Announce Strategic Partnership to Enhance Cardiovascular Careby December 10, 2024PR Newswire
Live from ASH 2024 | 1.5-Year Follow-Up Data from a Global Study of Olverembatinib Reaffirms Potential in Overcoming Resistance/Intolerance to Ponatinib or Asciminibby December 10, 2024PR Newswire
Live from ASH 2024 | First Dataset of Olverembatinib as Second-Line Therapy in Patients with Non-T315I-Mutant CP-CML Presented in Oral Reportby December 10, 2024PR Newswire
การบริจาคด้านสภาพภูมิอากาศเพิ่มขึ้น 20% ในปี 2566 แซงหน้าการเติบโตของการบริจาคเพื่อการกุศลทั่วโลกby December 10, 2024PR Newswire
The new battleground for commercial card providers: Rewards and flexibility, Ascenda report revealsby December 10, 2024PR Newswire
Live from ASH 2024 | Ascentage Pharma’s Bcl-2 Inhibitor Lisaftoclax in Combinations Demonstrates Potential Clinical Benefit in Patients with Prior Exposure to Venetoclaxby December 10, 2024PR Newswire
Live from ASH 2024 | 1.5-Year Follow-Up Data from a Global Study of Olverembatinib Reaffirms Potential in Overcoming Resistance/Intolerance to Ponatinib or Asciminibby December 10, 2024PR Newswire
Bybit Web3 Boosts its Supports to L1 Ecosystems at Taipei Blockchain Week 2024 with Co-hosted Solana and Sui Eventsby December 10, 2024PR Newswire
ST Engineering iDirect Releases Industry-first Breakthrough Multi-Orbit Capabilityby December 10, 2024PR Newswire
PENTAX Medical obtained US FDA 510(k) clearance for new models of the PENTAX Medical i20c Video Endoscope Seriesby December 10, 2024PR Newswire
Recurrent Energy Signs 300 MW Power Purchase Agreement with Major U.S. Tech Company in Spainby December 10, 2024PR Newswire
Syntara announces positive interim data in Phase 2 study of SNT-5505 in myelofibrosisby December 10, 2024PR Newswire
SurplusGLOBAL to Participate in SEMICON JAPAN 2024, Showcasing AI-Based ‘SemiMarket’ and Legacy Equipment Solutionsby December 10, 2024PR Newswire
Introducing the Gianna Lullume Smart Infant Sleep Device: A Revolutionary Solution for Infant Sleep Now on Kickstarterby December 10, 2024PR Newswire
Infinix Introduces Vibrant New Colors for the HOT 50 Series: A Bold Lifestyle Statement for the New Yearby December 10, 2024PR Newswire
Noah Holdings 2024 Corporate Open Day: Driving Global Expansion and Sophisticated Solutions for Mandarin-Speaking Clientsby December 10, 2024PR Newswire
Ampace’s JP30 Cylindrical Lithium Battery will debut on 12th Dec: Unleashing a New Era of Powerful Technologyby December 10, 2024PR Newswire
